suramin

DRUG17 trials

Sponsors

National Cancer Institute (NCI), Emory University, University of Arkansas, Eastern Cooperative Oncology Group, SWOG Cancer Research Network

Conditions

Acute Kidney InjuryAdrenocortical CarcinomaAutism Spectrum DisordersBladder CancerBladder NeoplasmsBrain and Central Nervous System TumorsBreast CancerCarcinoma, Non Small Cell Lung

Phase 1

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

CompletedNCT00001381

National Cancer Institute (NCI)Bladder Neoplasms, Carcinoma, Transitional Cell

Start: 1994-03-31End: 2000-12-31Target: 18Updated: 2008-03-04

Suramin in Treating Patients With Recurrent Bladder Cancer

CompletedNCT00006476

Cancer Research UKBladder Cancer

Start: 2000-10-31End: 2007-10-31Target: 15Updated: 2013-06-26

Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer

CompletedNCT00054028

National Cancer Institute (NCI)Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer

Start: 2002-12-31End: 2008-03-31Updated: 2015-03-17

Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer

CompletedNCT00066768

National Cancer Institute (NCI)Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer

Start: 2003-07-31Updated: 2013-06-04

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

CompletedNCT00003038

Mayo ClinicAdrenocortical Carcinoma, Breast Cancer, Colorectal Cancer +2

Start: 1997-10-31End: 2003-01-31Updated: 2011-08-03

Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer

CompletedNCT00083109

National Cancer Institute (NCI)Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer

Start: 2004-03-31End: 2008-03-31Updated: 2015-05-25

University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial

CompletedNCT02508259

University of California, San DiegoAutism Spectrum Disorders

Start: 2015-05-31End: 2016-04-30Updated: 2019-07-16

Phase 2

A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma

CompletedNCT00001266

National Cancer Institute (NCI)Prostatic Neoplasm

Start: 1990-10-31End: 2003-08-31Target: 70Updated: 2008-03-04

Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

CompletedNCT00006929

National Cancer Institute (NCI)Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer

Start: 2000-09-30Target: 82Updated: 2013-06-04

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

CompletedNCT00002652

University of ArkansasMultiple Myeloma and Plasma Cell Neoplasm

Start: 1995-05-31End: 2004-02-29Updated: 2013-02-04

Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

CompletedNCT00004073

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBrain and Central Nervous System Tumors

Start: 1999-12-31End: 2004-06-30Target: 54Updated: 2012-05-03

Suramin in Treating Patients With Recurrent Primary Brain Tumors

CompletedNCT00002639

Emory UniversityBrain and Central Nervous System Tumors

Start: 1995-07-31End: 2004-05-31Updated: 2013-06-21

S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery

TerminatedNCT00002921

SWOG Cancer Research NetworkAdrenocortical Carcinoma

Start: 1997-03-31End: 2004-01-31Updated: 2012-10-05

Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer

CompletedNCT01671332

University of Wisconsin, MadisonCarcinoma, Non Small Cell Lung

Start: 2012-06-30End: 2016-06-16Updated: 2020-05-12

Study of Suramin in Subjects With Furosemide-Resistant AKI

Rediscovery Life SciencesAcute Kidney Injury

Start: 2020-11-13End: 2023-12-22Updated: 2023-05-03

Phase 3

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

CompletedNCT00002723

National Cancer Institute (NCI)Prostate Cancer

Start: 1996-01-31End: 2008-03-31Updated: 2013-02-28

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

CompletedNCT00002723

National Cancer Institute (NCI)Prostate Cancer

Start: 1996-01-31End: 2008-03-31Updated: 2013-02-28

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

CompletedNCT00002881

Eastern Cooperative Oncology GroupProstate Cancer

Start: 1996-10-31Updated: 2010-11-09